Coutts A A, Anavi-Goffer S, Ross R A, MacEwan D J, Mackie K, Pertwee R G, Irving A J
Department of Biomedical Sciences, University of Aberdeen, Scotland, AB25 2ZD, United Kingdom.
J Neurosci. 2001 Apr 1;21(7):2425-33. doi: 10.1523/JNEUROSCI.21-07-02425.2001.
Agonist-induced internalization of G-protein-coupled receptors is an important mechanism for regulating receptor abundance and availability at the plasma membrane. In this study we have used immunolabeling techniques and confocal microscopy to investigate agonist-induced internalization and trafficking of CB(1) receptors in rat cultured hippocampal neurons. The levels of cell surface CB(1) receptor immunoreactivity associated with presynaptic GABAergic terminals decreased markedly (by up to 84%) after exposure to the cannabinoid agonist (+)-WIN55212, in a concentration-dependent (0.1-1 microm) and stereoselective manner. Inhibition was maximal at 16 hr and abolished in the presence of SR141716A, a selective CB(1) receptor antagonist. Methanandamide (an analog of an endogenous cannabinoid, anandamide) also reduced cell surface labeling (by 43% at 1 microm). Differential labeling of cell surface and intracellular pools of receptor demonstrated that the reduction in cell surface immunoreactivity reflects agonist-induced internalization and suggests that the internalized CB(1) receptors are translocated toward the soma. The internalization process did not require activated G-protein alpha(i) or alpha(o) subunits. A different pattern of cell surface CB(1) receptor expression was observed using an undifferentiated F-11 cell line, which had pronounced somatic labeling. In these cells substantial CB(1) receptor internalization was also observed after exposure to (+)-WIN55212 (1 microm) for relatively short periods (30 min) of agonist exposure. In summary, this dynamic modulation of CB(1) receptor expression may play an important role in the development of cannabinoid tolerance in the CNS. Agonist-induced internalization at presynaptic terminals has important implications for the modulatory effects of G-protein-coupled receptors on neurotransmitter release.
激动剂诱导的G蛋白偶联受体内化是调节受体丰度及在质膜上可用性的重要机制。在本研究中,我们运用免疫标记技术和共聚焦显微镜来研究激动剂诱导的CB(1)受体在大鼠培养海马神经元中的内化及转运。暴露于大麻素激动剂(+)-WIN55212后,与突触前GABA能终末相关的细胞表面CB(1)受体免疫反应性水平显著降低(高达84%),呈浓度依赖性(0.1 - 1微摩尔)且具有立体选择性。抑制作用在16小时时达到最大,且在选择性CB(1)受体拮抗剂SR141716A存在时消失。甲烷酰胺(内源性大麻素花生四烯酸乙醇胺的类似物)也降低了细胞表面标记(1微摩尔时降低43%)。对受体细胞表面和细胞内池的差异标记表明,细胞表面免疫反应性的降低反映了激动剂诱导的内化,并提示内化的CB(1)受体向胞体转运。内化过程不需要激活的G蛋白α(i)或α(o)亚基。使用未分化的F-11细胞系观察到细胞表面CB(1)受体表达的不同模式,该细胞系有明显的胞体标记。在这些细胞中,暴露于(+)-WIN55212(1微摩尔)相对较短时间(30分钟)的激动剂后,也观察到大量CB(1)受体内化。总之,CB(1)受体表达的这种动态调节可能在中枢神经系统大麻素耐受性的发展中起重要作用。激动剂在突触前终末诱导的内化对G蛋白偶联受体对神经递质释放的调节作用具有重要意义。